| Literature DB >> 29403704 |
Xiao-Fei Chen1,2, Hai-Tang Wu1,2, Guang-Guo Tan1,2, Zhen-Yu Zhu1,2, Yi-Feng Chai1,2.
Abstract
With the expansion of herbal medicine (HM) market, the issue on how to apply up-to-date analytical tools on qualitative analysis of HMs to assure their quality, safety and efficacy has been arousing great attention. Due to its inherent characteristics of accurate mass measurements and multiple stages analysis, the integrated strategy of liquid chromatography (LC) coupled with time-of-flight mass spectrometry (TOF-MS) and ion trap mass spectrometry (IT-MS) is well-suited to be performed as qualitative analysis tool in this field. The purpose of this review is to provide an overview on the potential of this integrated strategy, including the review of general features of LC-IT-MS and LC-TOF-MS, the advantages of their combination, the common procedures for structure elucidation, the potential of LC-hybrid-IT-TOF/MS and also the summary and discussion of the applications of the integrated strategy for HM qualitative analysis (2006-2011). The advantages and future developments of LC coupled with IT and TOF-MS are highlighted.Entities:
Keywords: Herbal medicine (HM); High-performance liquid chromatography (HPLC); Ion trap mass spectrometry (IT-MS); Time-of-flight mass spectrometry (TOF-MS)
Year: 2011 PMID: 29403704 PMCID: PMC5760787 DOI: 10.1016/j.jpha.2011.09.008
Source DB: PubMed Journal: J Pharm Anal ISSN: 2214-0883
Combination of TOF-MS and IT-MS for qualitative analysis of HM samples.
| Analytes | Matrix | LC/stationary phase | Analyzers | Year | Ref. |
|---|---|---|---|---|---|
| 4 N-alkylamides | HPLC/C18 | IT-TOF/MS | 2011 | ||
| 21 compounds including amino acids, phenolic acids, flavonoid glycoside, terpene glycoside and phthalide | HPLC/C18 | DAD-TOF-MS; IT-MS | 2011 | ||
| Over 39 compounds | Fructus | UFLC/C18 | IT-TOF/MS | 2011 | |
| 18 phenolic constituents, including moscatilin and gigantol | HPLC/C18 | IT-TOF/MS | 2010 | ||
| Rutaecarpine and its 2 derivatives | Standard compound | IT-TOF/MS | 2010 | ||
| 46 compounds including 3 phenolic compounds and 1 triterpenoid in licorice extract; 25 compounds in rat plasma | Licorice and rat plasma | HPLC/C18 | DAD; TOF-MS;QIT-MS | 2010 | |
| 62 flavone and isoflavone glycoconjugate | Root and leaf tissues of | HPLC/C18 | IT-MS | 2010 | |
| 5 lignans components | HPLC/C18 | IT-TOF/MS | 2010 | ||
| Salvinorin A | TLC/SiO2 | DESI-TOF-MS; IT-MS | 2010 | ||
| Phenolic compounds | Olive leaf | HPLC/C18 | TOF-MS; IT-MS | 2010 | |
| Flavonoids, phenolic acids, ellagitanins, hexahydroxydiphenoyl and derivatives, etc. | HPLC/C18 | DAD; TOF-MS; IT-MS | 2010 | ||
| Gallotannins | Chinese galls | – | MALDI-QIT-TOF/MS | 2009 | |
| 30 ginsenosides and 20 lignans | HPLC/C18 | IT-TOF/MS | 2009 | ||
| 28 cynandione A derivatives | Radix | HPLC/C18 | IT-MSn; QTOF-MS | 2009 | |
| 23 furocoumarins | Radix | HPLC/C18 | DAD; QIT-MS | 2009 | |
| Proanthocyanidin | Blueberry leaves | HPLC/C18 | IT-TOF/MS | 2009 | |
| 25 dibenzocyclooctadiene lignans, including seven groups of lignan isomers | HPLC/C18 | UV; IT-MS | 2009 | ||
| Phenolic compounds including verbascoside and its derivatives, diglucuronide derivatives of apigenin and luteolin, and eukovoside. gardoside, verbasoside, cistanoside F, theveside, campneoside I, chrysoeriol-7-diglucuronide, forsythoside A and acacetin-7-diglucuronide | Lemon verbena extract | HPLC/C18 | DAD-TOF-MS; IT-MS | 2009 | |
| Pregnane glycosides | HPLC/C18 | IT-TOF/MS | 2009 | ||
| 21 lignans in Schisandra chinensis; 11 lignans in rat plasma | HPLC/C18 | DAD; TOF-MS; QIT-MS | 2009 | ||
| 10 constituents including resveratroloside, polydatin, emodin-8-O-glucoside, resveratrol, torachryson-8-O-glucoside, emodin-1-O-glucoside, torachryson-8-O-(6′-acetyl)glucoside, physcion-8-O-glucoside, physcion-8-O-(6′-acetyl)glucoside and emodin | HPLC/C18 | QIT-TOF/MS | 2009 | ||
| 25 anthocyanins | Blueberry | HPLC/C18 | UV; IT-TOF/MS | 2009 | |
| C-20-nonoxygenated ent-kauranes and two subtypes of C-20-oxygenated ent-kauranes | Standard compounds | – | IT-MSn; QTOF-MS | 2008 | |
| Major components from Astragali Radix | 43 Radix | HPLC/C18 | IT-TOF/MS | 2008 | |
| Anthocyanins and chlorogenic acid | Dried calyces of | CE | IT-MS | 2008 | |
| 87 compounds including non-target components | HPLC/C18 | IT-TOF/MS | 2008 | ||
| Terpene lactones | Standard compounds | – | IT-MS | 2008 | |
| 8 C-21 steroidal glycosides | HPLC/C18 | IT-MS | 2008 | ||
| 7 tropane alkaloid including tropine, belladonnine, norhyoscyamine, apoatropine, hyoscyamine, 6beta-hydroxyhyoscyamine, and scopolamine | CE | IT-MS | 2008 | ||
| 40 phenolic and diterpenoid constituents | Radix | HPLC/C18 | DAD; QIT-MS | 2007 | |
| Dammarane-type triterpenoid saponins | – | ESI-IT-MS | 2007 | ||
| Sesamin and gmelinol | Standard compounds | – | IT-TOF/MS | 2007 | |
| 7 flavonolignans including Silychristins A and B , silydianin , silybins A and B, and isosilybins A and B | Semi-microHPLC/C18 | IT-TOF/MS | 2007 | ||
| Resveratrol glycosides including resveratrol diglucoside (M1), trans- and cis-resveratrol acetylhexosides | Transgenic | HPLC/C18 | UV; QTOF-MS; IT-MS | 2007 | |
| Podophyllotoxin and its 4′-demethyl-4beta-substituted derivatives | Standard compounds | – | IT-TOF/MS | 2007 | |
| Puerarin | Standard compounds | – | IT-TOF/MS | 2007 | |
| 13 steroid saponins | Rhizomes of | – | QTOF-MS; IT-MS | 2006 | |
| Differentiation of 3 pairs of aconite alkaloid isomers | – | QTOF-MS;IT-MS | 2006 | ||
| 14 betacyanins | – | MALDI-QIT-TOF/MS | 2006 |
Combination of TOF-MS and IT-MS for analysis of metabolites in HMs and HM-treated biological samples.
| Analytes | Metabolite | Matrix | LC/stationary phase | Analyzers | Year | Ref. |
|---|---|---|---|---|---|---|
| (+)-Praeruptorin B (dPB) and (+)-praeruptorin E (dPE) from | Human: dPB:B1–B9; dPE:E1–E13 rat: dPB:B1–B8; dPE:E1–E13 | Human and rat liver microsomes | HPLC/C18 | IT-MS | 2011 | |
| Traditional Chinese medicine tongxinluo | 1-Methyladenosine, indoxyl sulfate, hippuric acid, riboflavin, coproporphyrin, and p-cresol glucuronide | Endothelial dysfunction rats urinary | UFLC/C18 | IT-TOF/MS | 2011 | |
| 5 Schisandra lignans from | 44 metabolites | Rat urine | HPLC/C18 | IT-TOF/MS | 2010 | |
| Salvianolic acid A from | 5 metabolites including SalA-monoglucuronide, monomethyl-SalA-monoglucuronide, mono-methyl-SalA, dimethyl-SalA and dimethyl-SalA-monoglucuronide, | Rat plasma | HPLC/C18 | IT-MS | 2009 | |
| Tectorigenin | 7 phase II metabolities | Rat bile | HPLC/C18 | IT-MS | 2008 | |
| Ginkgolide B | 3 metabolites in urine;1 hydroxyl metabolite in liver | Rat urine and liver | HPLC/C18 | IT-MS | 2008 | |
| Interaction between tanshinone IIA and warfarin | Warfarin metabolite | Rat blood and urine, human serum albumin | HPLC/C18 | IT-MS | 2008 |
Figure 1TOF-MS spectra (a) and IT-MS1–5 spectra (b) of salvianolic acid B.
Figure 2HPLC–UV chromatogram monitored at 280 nm (a), TIC profile from HPLC/ESI-TOF-MS (b), and TIC profile from HPLC/ESI–MS (c) of phenolics and diterpenoids in Radix Salvia miltiorrhizae.
Figure 3The proposed fragmentation pathways of licobenzofuran (a), licochalcone D (b), licoisoflavone (c) and gancaonin L (d).